Anti-HBs levels among children and adolescents with complete immunization schedule against hepatitis B virus. A cross-sectional study in blumenau, State of Santa Catarina, Brazil, 2007-2008;Níveis de anti-HBs entre crianças e adolescentes com o esquema completo de imunização contra o vírus da hepatite B. Um estudo transversal em Blumenau, Estado de Santa Catarina, 2007-2008

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 44, Issue 4, 2011, Pages 412-415

  do Livramento, Andréa ^a   de Cordova, Caio Mauricio Mendes ^b   Scaraveli, Natália Gazzoni ^a   Tonial, Gabriela Chiochetta ^a   Spada, Celso ^a   Treitinger, Arício ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b REGIONAL UNIVERSITY OF BLUMENAU   (Brazil)

Author keywords

HBV; Immunity; Vaccination

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS VACCINE;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BRAZIL; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; MASS IMMUNIZATION; POPULATION RESEARCH; SCHOOL CHILD; SEROLOGY; VACCINATION;

ADOLESCENT; BRAZIL; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION SCHEDULE; MALE;

HEPATITIS B VIRUS;

EID: 81455128924     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822011005000046     Document Type: Article

References (30)

1. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341:22-26.
2. Juszczyk J. Clinical course and consequences of hepatitis B infection. Vaccine 2000; 18:23-25.
3. Slowik M, Jhaveri R. Hepatitis B and C viruses in infants and young children. Semin Pediatr Infect Dis 2005; 16:296-305.
4. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005; 34:1-3.
5. Ott MJ, Aruda M. Hepatitis B vaccine. J Pediatr Health Care 1999; 13:211-216.
6. Ferreira CT, Silveira TR. Hepatites virais: aspectos da epidemiologia e da prevenção. Rev Bras Epidemiol 2004; 7:473-487.
7. Kane M, Banatvala J, Da Villa G, Esteban R, Franco E, Goudeau A, et al. Are booster immunizations needed for lifelong hepatitis B immunity? Lancet 2000; 355:561-565.
8. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part I: Immunization of infants, children and adolescents. MMWR Recomm Rep 2005; 1-31.
9. Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 2007; 25:6958-6964.
10. Brazilian Health Ministry. National Immunization Program. Department of Health Surveillance. Brasília; 2003.
11. Motta VT, Wagner MB. Bioestatística. Caxias do Sul: Educs; 2003.
12. Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 2006; 2:1496-1502.
13. Madani TA. Trend in incidence of hepatitis B virus infection during a decade of universal childhood hepatitis B vaccination in Saudi Arabia. T Roy Soc Trop Med H 2005; 1-6.
14. Lu SN, Chen CH, Chen TM, Lee PL, Wang JH, Tung HD, et al. Hepatitis B virus infection in adolescents in a rural township - 15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 2006; 24:759-765.
15. Zanetti AR, Mariano A, Romano L, D'Amelio R, Chironna M, Coppola RC, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366:1379-1384.
16. Wainwright RB, Bulkow LR. Protection provided by hepatitis B vaccine in a Yupik Eskimo population - results of a 10- year study. J Infect Dis 1997; 175:674-677.
17. Liao SS, Li RC, Li H, Yang JY, Zeng XJ, Gong J, et al. Long-term effcacy of plasmaderived hepatitis B vaccine: a 15-year follow-up study among Chinese children. Vaccine 1999; 17:2661-2666.
18. Banatvala J, Damme PV, Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine 2001; 19:877-885.
19. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Bock HL, Leyssen M, Jacquet JM. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine 2010; 28:730-736.
20. Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Fotouhi A. Long-term protection provided by hepatitis B vaccine and need for booster dose: A meta-analysis. Vaccine 2009; 28:623-631.
21. Bracciale L, Fabbiani M, Sansoni A, Luzzi L, Bernini L, Zanelli G. Impact of Hepatitis B Vaccination in Children Born to HBsAg-Positive Mothers: a 20-year Retrospective Study. Infection 2009; 37:340-343.
22. Voigt AR, Strazer Neto M, Spada C, Treitinger A. Seroprevalence of hepatitis B and hepatitis C markers among children and adolescents in the south brazilian region - metropolitan area of Florianópolis, Santa Catarina. Braz J Infect Dis 2010; 14:60-65.
23. Luna EJ, Moraes JC, Silveira L, Salinas HS. Efficacy and safety of the Brazilian vaccine against Hepatitis B in newborns. Rev Saude Publica 2009; 43:1014-1020.
24. Lu JJ, Cheng CC, Chou SM, Hor CB, Yang YC, Wang HL. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan. Vaccine 2009; 27:6613-6618.
25. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997; 336:1855-1859.
26. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 2005; 142:333-341.
27. Linton LS, Peddecord KM, Seidman RL, Edwards C, Ross S, Gustafson K, et al. Implementing a seventh grade vaccination law: school factors associated with completion of required immunizations. Prevent Med 2003; 36:510-517.
28. Middleman AB, Robertson LM, Young C, Durant RH, Emans SJ. Predictors of time to completion of the hepatitis B vaccination series among adolescents. J Adolesc Health 1999; 25:323-327.
29. Oliveira MDS, Paggoto V, Matos MA, Kozlowski AG, Silva NR, Junqueira ALN, et al. Análise de fatores associados a não aceitação da vacina contra hepatite B em adolescentes escolares de baixa renda. Cien Saude Col 2007; 12:1247-1252.
30. Pyrsopoulos NT, Reddy KR. Hepatitis B. eMedicine; 2009. [cited 2011 Jan 27]. Available from: http://emedicine.medscape.com/article/177632-overview/.